Top 10 Takeaways: Intra Quarter Channel Checks Key Data Points for Your Investment Mosaic 1. Syntel optimistic about prospects (5/14/12). Takeaways: demand environment healthy, SYNT taking market share due to client service, & earnings protection from margin flexibility exists. 2. VanceInfo reports healthy results raising top line annual guidance, but EPS guidance unchanged (5/15/12). Takeaways: [...]
May 18, 2012 | 0 comments | Read More
A Little More Light Shed on Changes – Some Heavy Lifting Coming INVESTMENT CONCLUSION: CSC reported quarterly results roughly in line with the preliminary announcement. Although most of the bad news appears to be built into the stock price from a sentiment perspective, the prospects for the company over the short term are still uncertain [...]
May 18, 2012 | 0 comments | Read More
1. Cognizant lowers annual guidance (5/7/12) reviving Macro concerns. Takeaway: discretionary spending in Financial Services (capital markets) and pharma slow to start 2012. CTSH didn’t see the acceleration it expected in April. Hard to tell if there is another revision coming, but CTSH’s business model hasn’t changed. They have earned the benefit of the doubt. [...]
May 15, 2012 | 0 comments | Read More
IT services was in focus this week. Investor’s began the week on a sour note with Cognizant lowering annual guidance three months into the year. The adjustment comes on the heals of some lackluster March performances and mediocre June guidance. The combination of data points leads us to believe that a “Macro Scare Is In [...]
May 11, 2012 | 0 comments | Read More
The BPO demand environment took center stage this week as Genpact and EXLService reported results. Our takeaway was that the demand environment for BPO is healthy. There are a number of data points to confirm this. Solid quarterly results from the BPO players. Positive commentary regarding BPO provided by larger IT services firms and outsourcing [...]
May 8, 2012 | 0 comments | Read More
Our Thoughts: Cognizant reported in-line March qtr results, but gave June guidance below expectations and lowered annual guidance. The reason for the lowered guidance is due to a slowdown in discretionary spending in financial services and pharma. The current stock price reaction (down 18% as of this writing) is overdone, in our opinion. A murky [...]
May 8, 2012 | 0 comments | Read More
The reaction in the Cognizant’s stock yesterday was overdone, but that is something investors already knew. Short term investors are wondering is the guidance lowered enough. The answer lies in the strength of the macro, which we cannot predict. If the macro is not stable or doesn’t improve, it will impact more than Cognizant’s business [...]
May 8, 2012 | 0 comments | Read More